| Application no. and date | 19163475.7 (espacenet) (Federated) (European Patent Register), 20140220 | | Patent/reg. no. and date | DK/EP 3521312, 20210407 | | Publication date | 20190807 | | Priority no. and date | US 201361766798 P, 20130220, US 201361831809 P, 20130606 | | EP pub. no. and date |
EP 3521312 20190807 | | Effective date | | | Applicant/owner | Innate Pharma, 117 Avenue de Luminy
13009 Marseille, FR | | Applicant ref. no. | 1597255 | | Inventor | SICARD, Hélène, 52 Traverse Régny
13009 Marseille, FR,
BONNAFOUS, Cecile, 77 Route Leon Lachamp
13009 Marseille, FR,
BUFFET, Renaud, 35 Rue du Dôme
92100 Boulogne, FR | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 39/395 (2006.01) , A61P 35/00 (2006.01) , C07K 16/28 (2006.01) , C07K 16/30 (2006.01) | | Title | FORBINDELSE, DER BINDER SPECIFIKT TIL KIR3DL2, TIL ANVENDELSE TIL BEHANDLING AF PERIFERT T-CELLELYMFOM | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
